II. Epidemiology
- Farm settings and other rural areas
- Associated with entering rarely opened buildings
- Associated with increased rodent populations
- Most common in spring and summer
- Ages affected
- Mean age affected is middle aged adults
- Less commonly affects children
- United States
- Incidence U.S.: 890 cases since 1993 (as of 2023, cases/year: 30)
- First identified in 1993 in 4 corners (New Mexico, Arizona, Colorado and Utah)
- Now HPS has been identified in 31 states and Canada
- Initial cases were identified in southwest U.S.
- New Mexico
- Arizona
- California
- Worldwide
- North and South America (HPS clinical syndrome)
- In 2025, eight countries reported total of 229 cases and 59 deaths (25.7% CFR)
- Asia and Europe (HFRS clinical syndrome)
- Asia (esp. East China and South Korea) experience thousands of cases per year
- In 2023, Europe reported 1885 cases
- North and South America (HPS clinical syndrome)
- Outbreaks
- Shipborne person-to-person transmission of Andes Strain with HPS in May 2026 (WHO)
III. Pathophysiology
- Family Hantaviridae (and the genus Orthohantavirus)
- First described in soldiers during Korean War in 1950s
- Originally termed "Hantaan Virus" as cases occurred near Hantaan River, Korea
- Reclassified as of 2018 (previously classified as Bunyaviridae)
- Enveloped, Helical single stranded RNA Viruses (70-160 nm)
- Hantaviridae strains identified: 24
- First described in soldiers during Korean War in 1950s
- Anti-Message Sense RNA Viruses (Negative Stranded, -ssRNA)
- Anti-Message sense RNA (-ssRNA) need to first be transcribed into +ssRNA
- RNA dependent RNA Polymerase (RNA replicase, RdRp)
- RdRp is an enzyme carried by the -ssRNA virus within its capsid
- RdRp transcribes -ssRNA into +ssRNA within the host cell
- Translation follows +ssRNA transcription from -ssRNA (by RdRp)
- As with mRNA, +ssRNA translated by host ribosomes into Protein
- HPS Vectors (North America)
- Deer mouse (main vector): Sin Nombre Virus
- Cotton rat (Southeast U.S.): Black Creek Canal Virus
- Rice rat (Southeast U.S.): Bayou Virus
- White-footed mouse (Northeast U.S.): New York Virus
- Transmission
- Contact with the urine, faeces, or Saliva of infected rodents or by touching contaminated surfaces
- Inhalation of aerosolized rodent feces or Saliva is most common
- Highest risks for transmission include cleaning buildings with rodent infestations
- No identified Nosocomial Infections
- Person to person transmission in rare (Andes Strain only)
- Secondary transmission to healthcare workers is even less common (but can occur in early phase of illness)
- Contact with the urine, faeces, or Saliva of infected rodents or by touching contaminated surfaces
- Infection
- Hantaviruses infect endothelial, epithelial, dendritic, and Lymphocyte cells
- Viral Glycoproteins attach to cell surface receptors (esp. immature dentritic cells)
- From skin, virus spreads to Lymphatics
- Replication within regional Lymph Nodes
- Hantaviruses infect endothelial, epithelial, dendritic, and Lymphocyte cells
IV. Types: Clinical Syndromes
- Hantavirus Cardiopulmonary Syndrome (HCPS) or Hantavirus Pulmonary Syndrome (HPS)
- Described on this page
- Strains causing HPS are limited to the Americas
- Primary North American strain is Sin Nombre Virus (SNV)
- Other strains: New York, Black Creek Canal, Bayou, Monongahela
- Primary South American strain is Andes Virus (ANDV)
- Other strains: Laguna Negra, Oran, Choclo, Rio Mamore, Lechiguanas
- Primary North American strain is Sin Nombre Virus (SNV)
- Andes Strain (South America, esp. Argentina and Chile)
- Responsible for shipborne outbreak in May 2026
- Only strain demonstrating persion-to-person transmission
- Hemorrhagic fever with renal syndrome (HFRS)
- Strains limited to Asia and Europe (Hantaan, Dobrava, Seoul, Puumala)
- Associated with Acute Kidney Injury, Thrombocytopenia, fever, and Hypotension
- Note: HFRS is NOT covered on this page
V. Symptoms and Signs: Prodromal Phase (HPS)
- Follows 1 to 6 week (up to 8 week) Incubation Period after exposure
- Atypical cases may cause only prodromal phase
- Symptoms
- Mild febrile illness lasting 3-5 days
- Myalgias
- Gastrointestinal upset
- Headache
- Chills
- Malaise
- Signs
- Findings rarely seen in HPS (Negative Predictive Value)
- Rash, Conjunctivitis (occur with South American HPS)
- Rhinorrhea
- Pharyngitis
VI. Symptoms and Signs: Cardiopulmonary Phase (HPS)
- Symptoms
- Signs: Acute Pulmonary Edema
- Hypoxia
- Respiratory Failure within first 24 hours
- Cardiogenic Shock in severe cases
VII. Labs
- Hypoalbuminemia (later finding)
- Lactic Acidosis (later finding)
- Liver Function Tests elevated
- Chemistry Panel
- Hyponatremia (variably present)
- Renal Function Tests
- Acute Renal Failure may occur
-
Complete Blood Count
- Repeat in 8-12 hours if initial CBC normal
- Combination of all 4 criteria rare in other viral ID
- Thrombocytopenia (marker of severity)
- Leukocytosis with left-shift (severe Leukocytosis with DIC)
- Circulating immunoblasts
- Hemoconcentration (Hematocrit increased)
-
Serology (in U.S.)
- Sin Nombre Virus IgM (ELISA assay)
VIII. Imaging: Chest XRay (HPS)
- Diffuse Interstitial Edema
- Pleural Effusions
- Differs from ARDS by involving more central lung
IX. Differential Diagnosis (HPS)
X. Management (HPS)
- Early aggressive Intensive Care is associated with best outcomes
- Intensive cardiopulmonary support
- Mechanical Ventilation
- Vasopressors
- Invasive hemodynamic monitoring
- Careful fluid management
- Maintain normal to high filling pressures for Cardiac Output
- Avoid Pulmonary Edema (may avert Mechanical Ventilation)
- Initial broad spectrum Antibiotics (for other causes)
- Employ while awaiting SNV serologic titers
- Covers other causes on differential diagnosis
-
Ribavirin (Virazole)
- See Viral Hemorrhagic Fever for protocol
- Experimental measures being investigated
XI. Prognosis
-
Mechanical Ventilation required in 40% of HPS patients
- Better prognosis with early improvement in first few days (and Extubation in first week)
- Case fatality rate: 25% (up to 40-50% in some studies)
- One third of patients may die in first 48 hours of admission despite Intensive Care
- Disseminated Intravascular Coagulation (associated Hemorrhage) is among the main causes of death
- Survivors may have persistent small airway obstruction
- Survivors often recover within 1 week of illness
XII. Prevention
- Eliminate rodent populations in and around buildings
- Avoid rodent exposure
- No licensed treatment or Vaccine is available for Hantavirus infection
XIII. Resources
- Hantavirus Pulmonary Syndrome (StatPearls)